CLL-481 Ibrutinib Efficacy Across Subgroups of Patients With High-Risk Chronic Lymphocytic Leukemia: A Systematic Literature Review

Autor: Allan, John N., Kipps, Thomas J., Bokun, Alex, Maegawa, Rodrigo, O'Brien, Susan M.
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S356-S356
Databáze: ScienceDirect